Antiplatelets for stroke and transient ischemic attack (TIA)

References

Citations

1. Lip GYH, et al. (2006). Stroke prevention, search date July 2006. Online version of Clinical Evidence (15): 1–27.

2. Warburton E (2006). Stroke management, search date June 2006. Online version of Clinical Evidence (15): 1–15.

3. Sacco R, Elkind M (2000). Update on antiplatelet therapy for stroke prevention. Archives of Internal Medicine, 160(11): 1579–1582.

4. Albers G, et al. (2001). Antithrombotic and thrombolytic therapy for ischemic stroke. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest, 119(1, Suppl): 300S–320S.

5. Antithrombotic Trialists' Collaboration (2002). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ, 324(7329): 71–86.

6. Gibbons RJ, et al. (2002). ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina: A Report of the American College of Cardiology Foundation and the American Heart Association Task Force on Practice Guidelines, p. 50. Available online: http://www.acc.org/qualityandscience/clinical/guidelines/stable/stable_clean.pdf.

Author:	Douglas Dana Robin Parks, MS	Last Updated: May 14, 2007
Medical Review:	Anne C. Poinier, MD - Internal Medicine Andrew Swan, MD, CCFP, FCFP - Family Medicine Richard D. Zorowitz, MD - Physical Medicine and Rehabilitation
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.